Cardinal Health (NYSE:CAH) CAO Sells 2,302 Shares of Stock

Posted by Brian Himes on Aug 20th, 2026

Cardinal Health, Inc. (NYSE:CAH – Get Free Report) CAO Mary Scherer sold 2,302 shares of the company’s stock in a transaction dated Wednesday, August 19th. The shares were sold at an average price of $237.39, for a total transaction of $546,471.78. Following the transaction, the chief accounting officer directly owned 2,811 shares of the company’s stock, valued at approximately $667,303.29. This represents a 45.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Cardinal Health Stock Down 2.5%

Shares of CAH traded down $5.90 during mid-day trading on Thursday, hitting $228.95. The company had a trading volume of 1,588,640 shares, compared to its average volume of 2,033,699. Cardinal Health, Inc. has a 1-year low of $145.87 and a 1-year high of $258.30. The business’s 50-day simple moving average is $231.76 and its 200-day simple moving average is $217.68. The stock has a market cap of $53.25 billion, a PE ratio of 31.67, a P/E/G ratio of 1.26 and a beta of 0.49.

Cardinal Health (NYSE:CAH – Get Free Report) last posted its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, topping analysts’ consensus estimates of $2.42 by $0.49. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The company had revenue of $63.67 billion for the quarter, compared to the consensus estimate of $65.15 billion. During the same quarter last year, the firm posted $2.08 earnings per share. Cardinal Health’s revenue was up 5.8% on a year-over-year basis. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, sell-side analysts expect that Cardinal Health, Inc. will post 12.54 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be given a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Thursday, October 1st. Cardinal Health’s payout ratio is 28.49%.

Key Cardinal Health News

Here are the key news stories impacting Cardinal Health this week:

Positive Sentiment: RBC Capital began coverage with an “outperform” or “moderate buy” rating, citing Cardinal Health’s integration of higher-margin services as a potential driver of earnings and revenue outperformance. RBC Capital Starts Cardinal Health at Outperform
Positive Sentiment: A separate value-oriented analysis highlighted CAH’s long-term investment appeal, while recent results showed adjusted earnings per share of $2.91, well above the $2.42 consensus estimate, and full-year adjusted free cash flow of approximately $5 billion. Why Cardinal Health is a Top Value Stock for the Long-Term
Neutral Sentiment: Brokerages collectively maintain a “moderate buy” consensus rating. However, analysts and investors may be examining the quality of the earnings beat because part of the quarterly benefit came from a one-time tariff refund, making the 40% year-over-year adjusted EPS growth less representative of recurring performance. Cardinal Health’s Big Earnings Beat Hides a More Complicated Story
Negative Sentiment: Multiple executives and insiders reported sizable stock sales executed around $235–$236 per share. CEO Jason M. Hollar sold 124,529 shares across two transactions, while CEO Deborah Weitzman, Stephen M. Mason, Michelle D. Greene, and Jessica L. Mayer also reduced their holdings. The volume and concentration of these sales may be weighing on sentiment, although insider transactions can reflect diversification or scheduled selling rather than a change in business outlook. Cardinal Health Insider Transaction Filing

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. William Blair began coverage on Cardinal Health in a research note on Tuesday, April 28th. They issued an “outperform” rating on the stock. Morgan Stanley increased their target price on shares of Cardinal Health from $255.00 to $265.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th. Bank of America raised their price target on shares of Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a report on Thursday, July 2nd. TD Cowen lifted their price target on shares of Cardinal Health from $275.00 to $280.00 and gave the company a “buy” rating in a research report on Thursday, August 13th. Finally, Weiss Ratings raised shares of Cardinal Health from a “buy (b)” rating to a “buy (b+)” rating in a research report on Wednesday, August 5th. Sixteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, Cardinal Health currently has a consensus rating of “Moderate Buy” and an average price target of $266.56.

View Our Latest Analysis on CAH

Institutional Investors Weigh In On Cardinal Health

Large investors have recently modified their holdings of the stock. BlackRock Inc. purchased a new position in Cardinal Health in the 2nd quarter worth approximately $6,293,115,000. Wellington Management Group LLP lifted its position in shares of Cardinal Health by 247.5% during the second quarter. Wellington Management Group LLP now owns 14,860,271 shares of the company’s stock worth $3,530,206,000 after purchasing an additional 10,584,119 shares in the last quarter. Norges Bank acquired a new position in shares of Cardinal Health during the fourth quarter worth $790,344,000. Bank of America Corp DE acquired a new stake in Cardinal Health during the 2nd quarter valued at $689,066,000. Finally, Legal & General Group Plc acquired a new position in Cardinal Health in the 2nd quarter worth $438,870,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

About Cardinal Health

(Get Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.